Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
about
A cluster randomized trial evaluating electronic prescribing in an ambulatory care settingInterventions for improving medication reconciliation across transitions of careAdverse drug reactions.Epidemiology of medical errorDavid Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford RobertsExploring the causes of adverse events in NHS hospital practiceVoluntary electronic reporting of medical errors and adverse events. An analysis of 92,547 reports from 26 acute care hospitalsData-driven prediction of drug effects and interactionsThe incidence of prescribing errors in an eye hospitalEstimates of complications of medical care in the adult US populationThe effect of automated alerts on provider ordering behavior in an outpatient settingMedication errors: a prospective cohort study of hand-written and computerised physician order entry in the intensive care unit.Rational use of medicine in the pediatric age group: A summary on the role of clinical pharmacistsInformation technology interventions to improve medication safety in primary care: a systematic reviewA systematic review of adult admissions to ICUs related to adverse drug eventsOccurrence and preventability of adverse drug events in surgical patients: a systematic review of literatureAre interventions to reduce interruptions and errors during medication administration effective?: a systematic reviewPrescribing errors in hospital practiceVisual inspection of medications in preventing unexplained relapsesImpact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trialEffect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic reviewUse of a handheld computer application for voluntary medication event reporting by inpatient nurses and physiciansImplementing a 48 h EWTD-compliant rota for junior doctors in the UK does not compromise patients' safety: assessor-blind pilot comparisonAdverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodesCorrelation versus causation? Pharmacovigilance of the analgesic flupirtine exemplifies the need for refined spontaneous ADR reportingQuantifying age-related differences in information processing behaviors when viewing prescription drug labelsPrevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adultsApproaches to recording drug allergies in electronic health records: qualitative studyImpact of a warning CPOE system on the inappropriate pill splitting of prescribed medications in outpatientsPharmacist-Led Medication Reviews to Identify and Collaboratively Resolve Drug-Related Problems in Psychiatry - A Controlled, Clinical TrialValidation of a Crowdsourcing Methodology for Developing a Knowledge Base of Related Problem-Medication PairsInternational society for disease surveillance conference 2011: building the future of public health surveillanceAn integrated approach to computer-based decision support at the point of careStrategies for reducing medication errors in the emergency department.Adverse drug event reporting systems: a systematic reviewHow safe is primary care? A systematic review.Using a clinical data repository to estimate the frequency and costs of adverse drug events.Computerized decision support systems: improving patient safety in nephrology.A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.Does national regulatory mandate of provider order entry portend greater benefit than risk for health care delivery? The 2001 ACMI debate. The American College of Medical Informatics.
P2860
Q21203728-D104A9A4-F2B0-4388-A8B6-2E4012E64270Q24197704-0D8E9B0C-AE98-489B-A352-353DCBB30A70Q24524192-AEFD94D3-FBFF-43D6-B0FC-A9759F73BB38Q24524722-9EDBE33C-6AFB-47E7-8EC0-71C89BB75137Q24531987-417A5309-9CE4-48EE-8BA9-AC08331AA5BAQ24537471-328A1001-EE4B-4A2F-8551-ECE794418375Q24548816-C629DCFB-048D-4828-B3A1-484593DF201AQ24599300-4D9A4E4D-F13C-4F4D-A65A-D57E039E0803Q24794510-91E6D93E-B233-4122-B083-FA7A903727ECQ24800254-8DBBAC87-D524-4729-840D-061B33339A3EQ24810442-67CF64BF-11C1-4C5F-A4C1-AAB296F876F1Q24813401-B95E5A56-326D-4EDF-B085-4DD682ABE99AQ26822804-FA78FDD0-C325-4B32-8B0E-17FBF064E9EBQ26829102-A79203CE-C768-4F2B-8102-B791EF423940Q26997090-5D91989F-2702-42AD-8E2C-05361F3A677CQ26999373-E9814F3B-DEF2-4784-A038-4F172FA2F479Q26999724-D7398E4A-C656-4E24-AA41-A42ED3C1C53EQ27021830-1CC5E2B3-C8A4-4F12-9AAF-850E2DE131AAQ28193810-386AC648-D471-46BC-9964-0A20922D9777Q28194958-48C6245B-CE70-4980-B1D4-A0EC217ECDAFQ28297440-B71CBDA0-E062-4E9B-BEBB-6768C7BB43D6Q28384107-678E3933-E06C-43E6-932B-6B112D65A4F3Q28387939-B8FCF271-A474-4558-B706-C63F899663A9Q28474740-0E7F75D6-8B40-4456-BADF-DF943BDCA746Q28477448-9F0F23CF-20B7-4A85-A9BC-800A5BC1AA1DQ28480427-17AEF7D3-13FA-4E73-A592-4E4B20871354Q28536709-F10DF967-0110-47BF-812A-98EBB79B5213Q28537940-2D3CE19A-BEE7-4ED2-B7AA-765E0ECCFA93Q28542540-2B49F953-5708-48FF-83EC-D4D9639C831CQ28550748-E2DB6747-52BB-47B8-8B8B-EF51DF705010Q28647469-C6D2D045-5CEC-42A5-B760-1A217FA5B55DQ28732714-9BA094F1-2F48-4A4A-9CA0-10FCDD74954DQ28762797-E4C98E79-416C-4E3C-9316-F542B7EC61A5Q30217869-C3378696-9933-4E21-A4F6-13CD49CC3893Q30251709-04C956F5-391E-4BFF-AD23-8B38BC4FEB55Q30251987-5AD05AE1-F416-4CAA-97D6-C39DEA89E62AQ30308660-E59EF5D3-362B-446F-AAA0-C2BA482D676BQ30356168-9F79E31B-CC14-4C76-9BBF-262F3AE63F5BQ30449486-B3AC4268-DB34-49C4-8C50-13ADC518266BQ30450174-0AD683BD-5398-424F-AA94-05A8ED74B6E7
P2860
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@ast
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@en
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@nl
type
label
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@ast
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@en
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@nl
prefLabel
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@ast
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@en
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@nl
P2093
P1476
Incidence of adverse drug even ...... n. ADE Prevention Study Group.
@en
P2093
B J Sweitzer
D J Cullen
L A Petersen
R Hallisey
P356
10.1001/JAMA.1995.03530010043033
P407
P577
1995-07-01T00:00:00Z